| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |